UnitedHealth investors wary and looking for Medicare strategic change
NEW YORK, May 16 (Reuters) - UnitedHealth Group (UNH.N), opens new tab investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic changes in its Medicare Advantage health insurance business over the next year.
On Wednesday, the Wall Street Journal reported that UnitedHealth was the subject of a criminal probe at the Justice Department, just one day after the company withdrew its financial outlook and said Group CEO Andrew Witty was leaving.
The blows are eroding the allure the healthcare behemoth once held for investors.
UnitedHealth shares fell 14% in afternoon trading on Thursday to $274.35, near a five-year low. Shares had already plunged 18% on Tuesday, even as the company tried to assuage Wall Street concerns in a conference call. They are down 46% this year.
"Given that the investor call earlier this week was so brief and had a lack of detail, investors are on the lookout for another shoe to drop," said James Harlow, senior vice president at Novare Capital Management. The firm owns shares of UnitedHealth.
The DOJ criminal probe concerns the company's billing practices in its Medicare Advantage unit for older adults and people with disabilities, the Journal reported. UnitedHealth has said in regulatory filings that investigations, audits and reviews by a dozen different government agencies are underway.
UnitedHealth said in a Wednesday statement that it had not been notified of a criminal probe. "We stand by the integrity of our Medicare Advantage program," the company added.
Investors said they expect the company to turn around its profit outlook in 2026, at the earliest.
Exiting less profitable markets where it sells Medicare Advantage plans for people aged 65 and older and making health insurance plan design changes to offer access to lower-cost healthcare providers and a focus on cheaper generic drugs, rather than pricey branded ones, could be under consideration at UnitedHealth, said Jeff Jonas, a portfolio manager at Gabelli Funds.
Even after fixing plan issues, investors will likely need to price in a legal settlement that could cost the company over $1 billion, said Jonas.
And traditional cost-management measures that insurers have historically deployed, such as the use of prior authorizations and claim denials, have come under public and legislative criticism since the killing of UnitedHealthcare executive Brian Thompson last December, Jonas added.
In a first-quarter earnings call, the company noted that specialty care visits had generated higher costs after patients saw providers who are part of its Optum health services unit.
"Optum and OptumHealth are UnitedHealth's supposed antidote to the low-margin business," said Kevin Gade, chief operating officer at Bahl & Gaynor. "The fact that OptumHealth is at the epicenter only magnifies this stock move."
Optum is too tightly integrated with the company's Medicare Advantage plans for investors to expect a breakup of the insurance business and other healthcare operations, Jonas said.
Harlow at Novare Capital Management said that without strategic details on a turnaround for its insurance business, a breakup would not assuage low morale from investors.
For investors planning to ride out the challenges, last year's difficulties in CVS Health's Aetna insurance business come to mind. The company in 2024 missed earnings expectations for the first three quarters after facing rising healthcare costs and difficulty restructuring.
"There's no doubt UnitedHealth got behind the pricing curve relative to peers for 2025," said Gade, who added the company still has value due to its average $20 billion in free cash after covering expenses.
"I don't think it's as existential as the stock price may appear."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
6 hours ago
- Reuters
Exclusive: UnitedHealth eyes $1 billion deal to exit Latin America as insurer refocuses on US, sources say
NEW YORK, June 9 (Reuters) - UnitedHealth Group (UNH.N), opens new tab is weighing multiple bids for its Latin American operations, according to two people with direct knowledge of the matter, as the insurer buckles down after a series of unprecedented missteps that include the ouster of its CEO and a reported criminal accounting probe. The largest U.S. health insurer has been trying to exit Latin America since 2022, but the sale of Banmedica has taken on increasing urgency in recent months as the insurer took hits on multiple fronts, according to one of the people. New CEO Steve Hemsley told shareholders last week that he was determined to earn back their trust after an earnings miss and a Wall Street Journal report that the company was under criminal investigation for alleged Medicare fraud. UnitedHealth has said it was not notified by the Department of Justice and that it stands by the integrity of its operations. Hemsley replaced Andrew Witty as CEO, who had been in the post for only a matter of months following the murder of his predecessor, Brian Thompson, in New York in December while on his way to a meeting with investors. The company has four non-binding bids for its Banmedica subsidiary, which operates in Colombia and Chile, for about $1 billion, according to both people, who asked not to be identified because the talks are private. UnitedHealth's shares tumbled 25.5% in May alone and year-to-date are down 40%. UnitedHealth left Brazil in 2023 and Peru in March. It's aiming to get around $1 billion for Banmedica's operations in Colombia and Chile, the people said. The two people said the company expects to set a deadline for binding proposals as soon as July. UnitedHealth received bids from Washington, D.C.-based private equity firm Acon Investments; Sao Paulo-based private equity firm Patria Investments (PAX.O), opens new tab; Texas non-profit health firm Christus Health; and Lima-based healthcare and insurance provider Auna (GZ4.F), opens new tab, the people said. Auna is in talks with a financial partner, one of the sources added. Banmedica's annual earnings before income taxes, depreciation and amortization, or EBITDA, is more than $200 million a year. Patria and Christus Health declined to comment. UnitedHealth, Acon and Auna did not respond to requests for comment. UnitedHealth bought Banmedica in 2018, opens new tab, with CEO David Scott saying he was "establishing a foundation for growth in South America for the next decades." At the time, UnitedHealth paid around 12 times Banmedica's EBITDA, according to one of the people. Three years later, the insurer decided to leave Latin America as it grappled with losses in its largest operation in the region, Brazil's Amil, which had been acquired a decade earlier. It divested from its Brazilian operations in late 2023. Banmedica is currently profitable, but is considered too small by UnitedHealth. It serves over 2.1 million consumers through its health insurance programs and has around 4 million patient visits annually across its network of 13 hospitals and 143 medical centers. UnitedHealth booked an $8.3 billion loss last year related to the sale of its South American operations - $7.1 billion stemming from the Brazil exit and $1.2 billion from Banmedica. "These losses relate to our strategic exit of South American markets and include significant losses related to foreign currency translation effects," the company said in a February filing. Brazilian investment bank BTG Pactual ( opens new tab is advising UnitedHealth on the sale.
Daily Mail
3 days ago
- Daily Mail
Walmart makes major change to help older Americans
Walmart has announced a new partnership with Medicare Advantage to help elderly Americans maximize their benefits. Walmart, the largest grocery chain in the US, announced that Americans on Medicare Advantage care - a form of health insurance for over 65s provided by private insurers - will now be able to plug in their benefit card information to their online Walmart accounts. This will allow shoppers to see which items sold by Walmart are eligible for coverage or discounts under their program. Many Medicare Advantage programs offer supplemental benefits that cover wellness products or over-the-counter medications. While the products covered varies by each individual plan, the types of items likely to be available include vitamins and weight management supplements. Around two-thirds of Americans on Medicare Advantage programs don't use their over-the-counter benefits, according to the Consumer Healthcare Products Association. This is largely because they are not aware of which products are covered by their plans. Under the new Walmart program, consumers will see a 'benefit program eligible' icon appear over products that are covered by their specific plan. Centrum 50 Plus Multivitamin $7.99 Products, including vitamins from leading brands, may be available under your plan. Shop For those that prefer to shop in store, eligible products will show up with the same icon when scanned in the app. A tracker will also be available in seniors' Walmart account which shows how much of their benefits they have left to spend. The pilot will allow users to 'track their benefits spending in real time and check out with a mixed basket of healthy food, over the counter (OTC) products and general merchandise for same-day pickup or delivery in as soon as an hour,' Walmart said in a statement. 'We saw an opportunity to streamline the health benefits shopping journey, make it easier for customers to discover eligible items and offer convenient pickup and delivery options that fit their busy schedule,' Walmart's Ralph Clare said of the initiative. As part of the program Walmart is also launching a new platform for benefit providers, Walmart Everyday Health Signals. The platform will allow providers such as Medicare Advantage programs to integrate directly with Walmart. Together the pooled information will give 'AI-enabled guidance that empowers participating customers to make health-conscious choices,' Walmart wrote on its website. However, critics have already hit out at Walmart's use of AI in shopping basket scanners at its Sam's Club warehouses. Consumers will see a 'benefit program eligible' icon appear over eligible products The new technology allows customers to walk straight out of the store without going through a checkout. The move is controversial because it uses a network of cameras and sensors to track shoppers and their carts. In addition, the checkout-free experience requires all customers to use a smartphone and download the store's app. This could pose a challenge to older shoppers who may struggle with technology.
Reuters
4 days ago
- Reuters
Humana to back curbs to Medicare Advantage billing practices, WSJ reports
June 5 (Reuters) - Humana (HUM.N), opens new tab has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it. The company is willing to back new limits on lucrative payments insurers can gain from diagnoses recorded by nurse practitioners who visit millions of enrollees in their homes, according to a one-page policy overview shared with the staffers, the WSJ reported on Thursday. Humana did not immediately respond to a Reuters request for comment. Nearly half of the 65 million people covered by Medicare, the U.S. program for people aged 65 and older or with disabilities, are enrolled in Medicare Advantage plans run by private insurers. Insurers are paid a set rate for each patient, but can be paid more for patients with multiple health conditions. Last fall, staff working for Senators Mike Crapo and Ron Wyden, the leaders of the Senate Finance Committee, contacted Medicare Advantage insurers for suggestions on legislative steps that would address the potential misuse of home visits described in Journal articles, the newspaper reported citing people familiar with the matter. The Journal reported in February that the U.S. Department of Justice was examining UnitedHealth's (UNH.N), opens new tab practices for recording diagnoses that trigger extra payments to its Medicare Advantage plans. The healthcare conglomerate had then said it was unaware of any new probe. The WSJ has run a series of stories over the last several months detailing how UnitedHealth profited from using Medicare billing rules to its favor.
